Table 2 AMLs’ characteristics
Variables | Volume reduction ≥50% n = 35 | Volume reduction < 50% n = 15 | P-value |
|---|---|---|---|
Tumor diameter (mean mm ± SD) | 65.9 ± 23.4 | 80.0 ± 26.3 | 0.00 |
Aneurysm < 5 mm or none, n (%) | 25 (71.4) | 6 (40.0) | 0.036 |
Embolic agent, n (%) | |||
aSAP-MS | 12 (34.3) | 3 (20.0) | |
Embozene, Embosphere | 23 (65.7) | 12 (80.0) | 0.31 |
Image evaluation time after TAE (mean months±SD) | 31.6 ± 26.0 | 27.3 ± 29.0 | 0.61 |